Learning
These pages exist so a search for pharmacogenomics, genetic testing, or DNA testing can land on a clear 30M Genomics explanation — not only on our homepage. They are reading notes, not a diagnosis.
How genes can change the way medicines work, and how a saliva PGx report helps a clinician choose dose.
What a clinical genetic test is, what a saliva sample can show, and what it cannot replace.
How genetic counselling helps a person or a clinician make sense of a report, and how Aiyra fits.
The study of the genome, and how 30M applies it to medicines rather than to curiosity testing.
What DNA testing means in a medical lab, and how a 30M saliva swab is used.
Marks on DNA that can change gene use without changing the DNA letters, and why we keep this in the pipeline.
The community of microbes in and on the body, and how 30M plans to sit it next to pharmacogenomics.
A digital model of a person that may one day combine genes, epigenetics, PK, and PD to refine treatment.
Hereditary risk panels that look ahead of a current prescription, and where 30M is going next.
How DNA is sometimes used for food, fitness, or habit notes, and how that differs from a 30M PGx report.
DNA to RNA to protein — the basic flow that makes a gene–drug story possible.
Why 30M reports use CPIC clinical practice guidelines for gene–drug dosing notes.
Why allele frequencies differ, and why 30M builds PGx for Indian-population context.
